{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:18:51Z","timestamp":1788286731797,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171194"],"award-info":[{"award-number":["82171194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371204"],"award-info":[{"award-number":["82371204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271477"],"award-info":[{"award-number":["82271477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949204"],"award-info":[{"award-number":["91949204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24Y22800203"],"award-info":[{"award-number":["24Y22800203"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Perioperative neurocognitive disorders (PND) are common neurological complications in elderly surgical patients, for which effective mechanism-based therapies remain lacking. This study identifies ferroptosis, an iron-dependent lipid peroxidation-driven cell death, as a key pathological process in PND, and pharmacological inhibition of ferroptosis with ferrostatin-1 significantly ameliorated cognitive deficits in a surgery and anesthesia-induced mouse model of PND. Moreover, accumulation of glutamate has been observed in the brains of PND mice, which competitively inhibits the neuronal cystine\/glutamate antiporter system Xc\n                    <jats:sup>-<\/jats:sup>\n                    (via SLC7A11) to trigger glutathione depletion and ferroptotic cell death. Excessive glutamate production and release are driven by hyperexpression of glutamate-producing enzyme glutaminase 1 (GLS1) in activated microglia via STAT1-dependent transcriptional activation. Pharmacological inhibition of GLS1 with the selective inhibitors CB839 and BPTES suppressed ferroptosis, preserved synaptic plasticity, and improved cognitive performance in PND mice, indicating GLS1 as a potential therapeutic target of PND. Notably, elevated plasma GLS1 levels in PND patients correlated negatively with cognitive test scores (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.479,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and exhibited moderate diagnostic value across two independent cohorts (AUCs = 0.77 and 0.84), underscoring its clinical relevance as a potential biomarker. Collectively, our findings establish microglial GLS1 as a critical mediator of ferroptosis in PND and highlight its dual promise as a therapeutic target and diagnostic indicator.\n                  <\/jats:p>","DOI":"10.1038\/s41418-026-01833-3","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:51:41Z","timestamp":1788281501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting microglial glutaminase 1 protects against ferroptosis-driven cognitive impairment in perioperative neurocognitive disorders"],"prefix":"10.1038","author":[{"given":"Yiyan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanran","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-6319","authenticated-orcid":false,"given":"Xiaohuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-0151","authenticated-orcid":false,"given":"Jialin C.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-0078","authenticated-orcid":false,"given":"Jianhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"1833_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/ALN.0000000000002956","volume":"132","author":"RG Eckenhoff","year":"2020","unstructured":"Eckenhoff RG, Maze M, Xie Z, Culley DJ, Goodlin SJ, Zuo Z, et al. Perioperative neurocognitive disorder: state of the preclinical science. Anesthesiology. 2020;132:55\u201368.","journal-title":"Anesthesiology"},{"key":"1833_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/cns.13873","volume":"28","author":"H Kong","year":"2022","unstructured":"Kong H, Xu LM, Wang DX. Perioperative neurocognitive disorders: a narrative review focusing on diagnosis, prevention, and treatment. CNS Neurosci Ther. 2022;28:1147\u201367.","journal-title":"CNS Neurosci Ther"},{"key":"1833_CR3","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.2147\/JMDH.S431168","volume":"16","author":"NR Arefayne","year":"2023","unstructured":"Arefayne NR, Berhe YW, van Zundert AA. Incidence and factors related to prolonged postoperative cognitive decline (POCD) in elderly patients following surgery and anaesthesia: a systematic review. J Multidiscip Health. 2023;16:3405\u201313.","journal-title":"J Multidiscip Health"},{"key":"1833_CR4","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1016\/j.scib.2024.09.005","volume":"69","author":"S Jin","year":"2024","unstructured":"Jin S, Lu W, Zhang J, Zhang L, Tao F, Zhang Y, et al. The mechanisms, hallmarks, and therapies for brain aging and age-related dementia. Sci Bull. 2024;69:3756\u201376.","journal-title":"Sci Bull"},{"key":"1833_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106627","volume":"200","author":"M Que","year":"2024","unstructured":"Que M, Li S, Xia Q, Li X, Luo X, Zhan G, et al. Microbiota-gut-brain axis in perioperative neurocognitive and depressive disorders: Pathogenesis to treatment. Neurobiol Dis. 2024;200:106627.","journal-title":"Neurobiol Dis"},{"key":"1833_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"1833_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommen\u2019dations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"1833_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.904152","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Xia X, Basnet D, Zheng JC, Huang J, Liu J. Mechanisms of ferroptosis and emerging links to the pathology of neurodegenerative diseases. Front Aging Neurosci. 2022;14:904152.","journal-title":"Front Aging Neurosci"},{"key":"1833_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","volume":"105","author":"J Zheng","year":"2025","unstructured":"Zheng J, Conrad M. Ferroptosis: when metabolism meets cell death. Physiol Rev. 2025;105:651\u2013706.","journal-title":"Physiol Rev"},{"key":"1833_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"1833_CR11","doi-asserted-by":"crossref","unstructured":"Li Y, Sun M, Cao F, Chen Y, Zhang L, Li H, et al. The ferroptosis inhibitor liproxstatin-1 ameliorates LPS-induced cognitive impairment in mice. Nutrients. 2022;14:4599.","DOI":"10.3390\/nu14214599"},{"key":"1833_CR12","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1021\/acschemneuro.1c00131","volume":"12","author":"L Zhao","year":"2021","unstructured":"Zhao L, Gong H, Huang H, Tuerhong G, Xia H. Participation of mind bomb-2 in sevoflurane anesthesia induces cognitive impairment in aged mice via modulating ferroptosis. ACS Chem Neurosci. 2021;12:2399\u2013408.","journal-title":"ACS Chem Neurosci"},{"key":"1833_CR13","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.2147\/JIR.S503784","volume":"18","author":"L Lin","year":"2025","unstructured":"Lin L, Ling X, Chen T, Zhou Q, Huang J, Huang L, et al. Inhibition of hippocampal neuronal ferroptosis by liproxstatin-1 improves learning and memory function in aged mice with perioperative neurocognitive dysfunction. J Inflamm Res. 2025;18:2991\u20133007.","journal-title":"J Inflamm Res"},{"key":"1833_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41420-021-00454-8","volume":"7","author":"P Liu","year":"2021","unstructured":"Liu P, Yuan J, Feng Y, Chen X, Wang G, Zhao L. Ferroptosis contributes to isoflurane-induced neurotoxicity and learning and memory impairment. Cell Death Discov. 2021;7:72.","journal-title":"Cell Death Discov"},{"key":"1833_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"1833_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1113081","volume":"16","author":"G Fan","year":"2023","unstructured":"Fan G, Liu M, Liu J, Huang Y. The initiator of neuroexcitotoxicity and ferroptosis in ischemic stroke: glutamate accumulation. Front Mol Neurosci. 2023;16:1113081.","journal-title":"Front Mol Neurosci"},{"key":"1833_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06503-1","volume":"15","author":"C Han","year":"2024","unstructured":"Han C, Ge M, Xing P, Xia T, Zhang C, Ma K, et al. Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8(+) T cells. Cell Death Dis. 2024;15:145.","journal-title":"Cell Death Dis"},{"key":"1833_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1120-x","volume":"15","author":"B Wu","year":"2018","unstructured":"Wu B, Liu J, Zhao R, Li Y, Peer J, Braun AL, et al. Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate. J Neuroinflammation. 2018;15:79.","journal-title":"J Neuroinflammation"},{"key":"1833_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2290911","volume":"39","author":"R Cyriac","year":"2024","unstructured":"Cyriac R, Lee K. Glutaminase inhibition as potential cancer therapeutics: current status and future applications. J Enzym Inhib Med Chem. 2024;39:2290911.","journal-title":"J Enzym Inhib Med Chem"},{"key":"1833_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2020.11.038","volume":"92","author":"L Ding","year":"2021","unstructured":"Ding L, Xu X, Li C, Wang Y, Xia X, Zheng JC. Glutaminase in microglia: A novel regulator of neuroinflammation. Brain Behav Immun. 2021;92:139\u201356.","journal-title":"Brain Behav Immun"},{"key":"1833_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fncel.2019.00264","volume":"13","author":"G Gao","year":"2019","unstructured":"Gao G, Zhao S, Xia X, Li C, Li C, Ji C, et al. Glutaminase C regulates microglial activation and pro-inflammatory exosome release: relevance to the pathogenesis of Alzheimer\u2019s disease. Front Cell Neurosci. 2019;13:264.","journal-title":"Front Cell Neurosci"},{"key":"1833_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fimmu.2020.00161","volume":"11","author":"G Gao","year":"2020","unstructured":"Gao G, Li C, Zhu J, Wang Y, Huang Y, Zhao S, et al. Glutaminase 1 regulates neuroinflammation after cerebral ischemia through enhancing microglial activation and pro-inflammatory exosome release. Front Immunol. 2020;11:161.","journal-title":"Front Immunol"},{"key":"1833_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00759","volume":"22","author":"M Huang","year":"2025","unstructured":"Huang M, Li Y, Thomas AG, Sharma A, Liyanage W, Tichy T, et al. Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficits. Neurotherapeutics. 2025;22:e00759.","journal-title":"Neurotherapeutics"},{"key":"1833_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbi.2021.10.009","volume":"99","author":"C Ji","year":"2022","unstructured":"Ji C, Tang Y, Zhang Y, Li C, Liang H, Ding L, et al. Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression. Brain Behav Immun. 2022;99:231\u201345.","journal-title":"Brain Behav Immun"},{"key":"1833_CR25","doi-asserted-by":"crossref","unstructured":"Feng X, Liu J, Liang Z, Du X, Zhao L, Xie N, et al. Transcranial magnetic stimulation mitigates perioperative neurocognitive disorders by regulating the function of the glymphatic system. Cell Commun Signal. 2026;24:164.","DOI":"10.1186\/s12964-026-02751-0"},{"key":"1833_CR26","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.bbapap.2013.01.028","volume":"1834","author":"H Haslene-Hox","year":"2013","unstructured":"Haslene-Hox H, Tenstad O, Wiig H. Interstitial fluid-a reflection of the tumor cell microenvironment and secretome. Biochim Biophys Acta. 2013;1834:2336\u201346.","journal-title":"Biochim Biophys Acta"},{"key":"1833_CR27","first-page":"177","volume":"196","author":"A Ruiz-Iglesias","year":"2025","unstructured":"Ruiz-Iglesias A, Garc\u00eda-Aldea \u00c1, Nonnast E, Peregil RM, Ma\u00f1es S. Isolation of tumor interstitial fluid for metabolic determinations. Methods Cell Biol. 2025;196:177\u201392.","journal-title":"Methods Cell Biol"},{"key":"1833_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102697","volume":"62","author":"Q Liu","year":"2023","unstructured":"Liu Q, Wang X, Hu Y, Zhao JN, Huang CH, Li T, et al. Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis. Redox Biol. 2023;62:102697.","journal-title":"Redox Biol"},{"key":"1833_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.molcel.2015.11.017","volume":"61","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Liu X, Bai J, Tian X, Zhao X, Liu W, et al. Mitoguardin regulates mitochondrial fusion through MitoPLD and is required for neuronal homeostasis. Mol Cell. 2016;61:111\u201324.","journal-title":"Mol Cell"},{"key":"1833_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2147\/DDDT.S130514","volume":"11","author":"G Ganguly","year":"2017","unstructured":"Ganguly G, Chakrabarti S, Chatterjee U, Saso L. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease. Drug Des Devel Ther. 2017;11:797\u2013810.","journal-title":"Drug Des Devel Ther"},{"key":"1833_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23190","volume":"36","author":"H Shen","year":"2022","unstructured":"Shen H, Zhai L, Wang G. Hepcidin regulates neuronal ferroptosis: A mechanism for postoperative cognitive dysfunction. J Biochem Mol Toxicol. 2022;36:e23190.","journal-title":"J Biochem Mol Toxicol"},{"key":"1833_CR32","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.7150\/ijbs.69714","volume":"18","author":"C Wang","year":"2022","unstructured":"Wang C, Chen S, Guo H, Jiang H, Liu H, Fu H, et al. Forsythoside A mitigates Alzheimer\u2019s-like pathology by inhibiting ferroptosis-mediated neuroinflammation via Nrf2\/GPX4 axis activation. Int J Biol Sci. 2022;18:2075\u201390.","journal-title":"Int J Biol Sci"},{"key":"1833_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114862","volume":"379","author":"Y Li","year":"2024","unstructured":"Li Y, Ruan X, Sun M, Yuan M, Song J, Zhou Z, et al. Iron deposition participates in LPS-induced cognitive impairment by promoting neuroinflammation and ferroptosis in mice. Exp Neurol. 2024;379:114862.","journal-title":"Exp Neurol"},{"key":"1833_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0740-2","volume":"13","author":"Y Li","year":"2016","unstructured":"Li Y, Pan K, Chen L, Ning JL, Li X, Yang T, et al. Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction. J Neuroinflammation. 2016;13:268.","journal-title":"J Neuroinflammation"},{"key":"1833_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuro.2025.02.003","volume":"107","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang B, Jiang Y, Fu W. Tanshinone IIA mitigates postoperative cognitive dysfunction in aged rats by inhibiting hippocampal inflammation and ferroptosis: Role of Nrf2\/SLC7A11\/GPX4 axis activation. Neurotoxicology. 2025;107:62\u201373.","journal-title":"Neurotoxicology"},{"key":"1833_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-34240-8","volume":"16","author":"Y Yang","year":"2026","unstructured":"Yang Y, Hu W, Wu Z, Chen M, Li H, Cui J, et al. Morin improves postoperative cognitive dysfunction by mediating the miR-138-5p\/SIRT1 axis to regulate ferroptosis. Sci Rep. 2026;16:4186.","journal-title":"Sci Rep"},{"key":"1833_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115582","volume":"397","author":"J Zhong","year":"2026","unstructured":"Zhong J, Li L, Hou L, Yuan S, Zeng J, Zheng D, et al. Near-infrared light improves postoperative cognitive dysfunction by alleviating Lcn2-dependent ferroptosis induced neuronal injury. Exp Neurol. 2026;397:115582.","journal-title":"Exp Neurol"},{"key":"1833_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111234","volume":"222","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang A, Li R, Jiao M, Wen R, Zheng R. Electroacupuncture regulates ferroptosis to improve postoperative cognitive dysfunction in mice through mediating GRX1\/GSK-3beta\/Nrf2 axis. Brain Res Bull. 2025;222:111234.","journal-title":"Brain Res Bull"},{"key":"1833_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02318-5","volume":"18","author":"G Luo","year":"2021","unstructured":"Luo G, Wang X, Cui Y, Cao Y, Zhao Z, Zhang J. Metabolic reprogramming mediates hippocampal microglial M1 polarization in response to surgical trauma causing perioperative neurocognitive disorders. J Neuroinflammation. 2021;18:267.","journal-title":"J Neuroinflammation"},{"key":"1833_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11064-025-04416-9","volume":"50","author":"G Ma","year":"2025","unstructured":"Ma G, Jiang X, Meng X, Liu Z, Ma X, Wang H. Inhibition of NLRP3 inflammasome alleviates postoperative cognitive impairment by suppressing the HMGB-1\/TLR4\/NF-kappaB pathway. Neurochem Res. 2025;50:173.","journal-title":"Neurochem Res"},{"key":"1833_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106317","volume":"82","author":"Q Fu","year":"2020","unstructured":"Fu Q, Li J, Qiu L, Ruan J, Mao M, Li S, et al. Inhibiting NLRP3 inflammasome with MCC950 ameliorates perioperative neurocognitive disorders, suppressing neuroinflammation in the hippocampus in aged mice. Int Immunopharmacol. 2020;82:106317.","journal-title":"Int Immunopharmacol"},{"key":"1833_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02309-6","volume":"18","author":"SC Woodburn","year":"2021","unstructured":"Woodburn SC, Bollinger JL, Wohleb ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation. 2021;18:258.","journal-title":"J Neuroinflammation"},{"key":"1833_CR43","doi-asserted-by":"crossref","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T. Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. 2023;12:1012.","DOI":"10.3390\/cells12071012"},{"key":"1833_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148383","volume":"1812","author":"H Jia","year":"2023","unstructured":"Jia H, Liu X, Cao Y, Niu H, Lan Z, Li R, et al. Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury. Brain Res. 2023;1812:148383.","journal-title":"Brain Res"},{"key":"1833_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14456","volume":"30","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ye P, Zhu H, Gu L, Li Y, Feng S, et al. Neutral polysaccharide from Gastrodia elata alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis-mediated neuroinflammation via the NRF2\/HO-1 signaling pathway. CNS Neurosci Ther. 2024;30:e14456.","journal-title":"CNS Neurosci Ther"},{"key":"1833_CR46","doi-asserted-by":"crossref","unstructured":"Xu Y, Jia B, Li J, Li Q, Luo C. The interplay between ferroptosis and neuroinflammation in central neurological disorders. Antioxidants. 2024;13:395.","DOI":"10.3390\/antiox13040395"},{"key":"1833_CR47","doi-asserted-by":"crossref","unstructured":"Wang XY, Liu WG, Hou AS, Song YX, Ma YL, Wu XD, et al. Dysfunction of EAAT3 aggravates LPS-induced post-operative cognitive dysfunction. Membranes. 2022;12:317.","DOI":"10.3390\/membranes12030317"},{"key":"1833_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbi.2021.01.003","volume":"93","author":"Y Cui","year":"2021","unstructured":"Cui Y, Zhang Y, Zhao X, Shao L, Liu G, Sun C, et al. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation. Brain Behav Immun. 2021;93:312\u201321.","journal-title":"Brain Behav Immun"},{"key":"1833_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbi.2023.02.012","volume":"109","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhao R, Lv M, Xu X, Liu W, Li X, et al. ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression. Brain Behav Immun. 2023;109:331\u201343.","journal-title":"Brain Behav Immun"},{"key":"1833_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0151-1","volume":"11","author":"DJ Allison","year":"2014","unstructured":"Allison DJ, Ditor DS. The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J Neuroinflammation. 2014;11:151.","journal-title":"J Neuroinflammation"},{"key":"1833_CR51","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.03041","volume":"14","author":"TA Zerfu","year":"2024","unstructured":"Zerfu TA, Tareke AA, Genye T, Bayable M, Muleta A, Getu Z, et al. Revolutionising multi-sectoral nutrition policy: Insights from the Ethiopian National Information Platform for Nutrition (NiPN) approach. J Glob Health. 2024;14:03041.","journal-title":"J Glob Health"},{"key":"1833_CR52","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s11064-022-03771-1","volume":"48","author":"JV Andersen","year":"2023","unstructured":"Andersen JV, Schousboe A. Glial glutamine homeostasis in health and disease. Neurochem Res. 2023;48:1100\u201328.","journal-title":"Neurochem Res"},{"key":"1833_CR53","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1523\/JNEUROSCI.4241-05.2006","volume":"26","author":"J Masson","year":"2006","unstructured":"Masson J, Darmon M, Conjard A, Chuhma N, Ropert N, Thoby-Brisson M, et al. Mice lacking brain\/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J Neurosci. 2006;26:4660\u201371.","journal-title":"J Neurosci"},{"key":"1833_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2018.11.022","volume":"396","author":"P Dutar","year":"2019","unstructured":"Dutar P, Tolle V, Kervern M, Carcenac C, Carola V, Gross C, et al. GLS1 mutant mice display moderate alterations of hippocampal glutamatergic neurotransmission associated with specific adaptive behavioral changes. Neuroscience. 2019;396:175\u201386.","journal-title":"Neuroscience"},{"key":"1833_CR55","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamaneurol.2018.2941","volume":"76","author":"L Rumping","year":"2019","unstructured":"Rumping L, Buttner B, Maier O, Rehmann H, Lequin M, Schlump JU, et al. Identification of a loss-of-function mutation in the context of glutaminase deficiency and neonatal epileptic encephalopathy. JAMA Neurol. 2019;76:342\u201350.","journal-title":"JAMA Neurol"},{"key":"1833_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0058-z","volume":"10","author":"B Wu","year":"2015","unstructured":"Wu B, Huang Y, Braun AL, Tong Z, Zhao R, Li Y, et al. Glutaminase-containing microvesicles from HIV-1-infected macrophages and immune-activated microglia induce neurotoxicity. Mol Neurodegeneration. 2015;10:61.","journal-title":"Mol Neurodegeneration"},{"key":"1833_CR57","doi-asserted-by":"publisher","first-page":"e32995","DOI":"10.1371\/journal.pone.0032995","volume":"7","author":"L Zhao","year":"2012","unstructured":"Zhao L, Huang Y, Tian C, Taylor L, Curthoys N, Wang Y, et al. Interferon-alpha regulates glutaminase 1 promoter through STAT1 phosphorylation: relevance to HIV-1 associated neurocognitive disorders. PLoS ONE. 2012;7:e32995.","journal-title":"PLoS ONE"},{"key":"1833_CR58","doi-asserted-by":"publisher","first-page":"e76581","DOI":"10.1371\/journal.pone.0076581","volume":"8","author":"L Zhao","year":"2013","unstructured":"Zhao L, Huang Y, Zheng J. STAT1 regulates human glutaminase 1 promoter activity through multiple binding sites in HIV-1 infected macrophages. PLoS ONE. 2013;8:e76581.","journal-title":"PLoS ONE"},{"key":"1833_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121814","volume":"328","author":"D Neves","year":"2023","unstructured":"Neves D, Salazar IL, Almeida RD, Silva RM. Molecular mechanisms of ischemia and glutamate excitotoxicity. Life Sci. 2023;328:121814.","journal-title":"Life Sci"},{"key":"1833_CR60","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1158\/0008-5472.CAN-24-3478","volume":"85","author":"SL DeAngelo","year":"2025","unstructured":"DeAngelo SL, Zhao L, Dziechciarz S, Shin M, Solanki S, Balia A, et al. Recharacterization of the tumor suppressive mechanism of RSL3 identifies the selenoproteome as a druggable pathway in colorectal cancer. Cancer Res. 2025;85:2788\u2013804.","journal-title":"Cancer Res"},{"key":"1833_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","volume":"10","author":"H Liu","year":"2025","unstructured":"Liu H, Wang S, Wang J, Guo X, Song Y, Fu K, et al. Energy metabolism in health and diseases. Signal Transduct Target Ther. 2025;10:69.","journal-title":"Signal Transduct Target Ther"},{"key":"1833_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108523","volume":"161","author":"C Vagaggini","year":"2025","unstructured":"Vagaggini C, D\u2019Ursi P, Poggialini F, Fossa P, Francesconi V, Trombetti G, et al. Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents. Bioorg Chem. 2025;161:108523.","journal-title":"Bioorg Chem"},{"key":"1833_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01449-x","volume":"22","author":"X Li","year":"2024","unstructured":"Li X, Peng X, Li Y, Wei S, He G, Liu J, et al. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment. Cell Commun Signal. 2024;22:12.","journal-title":"Cell Commun Signal"},{"key":"1833_CR64","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jconrel.2023.11.054","volume":"365","author":"M Zheng","year":"2024","unstructured":"Zheng M, Xu H, Huang Y, Sun J, Zhang H, Lv Z, et al. Hypoxia-activated glutamine antagonist prodrug combined with combretastatin A4 nanoparticles for tumor-selective metabolic blockade. J Control Release. 2024;365:480\u201390.","journal-title":"J Control Release"},{"key":"1833_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175323","volume":"940","author":"W Xiao-Yan","year":"2023","unstructured":"Xiao-Yan W, Xiao-Xia Y, Peng-Fei S, Zong-Xue Z, Xiu-Li G. Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity. Eur J Pharm. 2023;940:175323.","journal-title":"Eur J Pharm"},{"key":"1833_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115306","volume":"252","author":"Y Chen","year":"2023","unstructured":"Chen Y, Tan L, Gao J, Lin C, Wu F, Li Y, et al. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics. Eur J Med Chem. 2023;252:115306.","journal-title":"Eur J Med Chem"},{"key":"1833_CR67","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/2211-5463.13319","volume":"12","author":"H Cederkvist","year":"2022","unstructured":"Cederkvist H, Kolan SS, Wik JA, Sener Z, Skalhegg BS. Identification and characterization of a novel glutaminase inhibitor. FEBS Open Bio. 2022;12:163\u201374.","journal-title":"FEBS Open Bio"},{"key":"1833_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-02018-6","volume":"23","author":"D Nan","year":"2025","unstructured":"Nan D, Yao W, Huang L, Liu R, Chen X, Xia W, et al. Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets. Cell Commun Signal. 2025;23:45.","journal-title":"Cell Commun Signal"},{"key":"1833_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117275","volume":"242","author":"H Wang","year":"2025","unstructured":"Wang H, Li X, Hu H, Gao Z. Glutaminase 1 inhibitors: Therapeutic potential, mechanisms of action, and clinical perspectives. Biochem Pharm. 2025;242:117275.","journal-title":"Biochem Pharm"},{"key":"1833_CR70","doi-asserted-by":"crossref","unstructured":"Tawfik GA, Lu M, De La Hoz M, Crugnola W, Jin Z, Moller D. Molecular and clinical considerations for anesthesia in the aging brain. Int J Mol Sci. 2025;26:10272.","DOI":"10.3390\/ijms262110272"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01833-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:02:21Z","timestamp":1788285741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01833-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":70,"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01833-3","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal procedures were approved by the Animal Care and Ethics Committee of Tongji University (approval No. TJAA06723107). The clinical study was conducted in two independent cohorts. The discovery cohort (Tongji Hospital) was approved by the Ethics Committee of Tongji Hospital and registered with the Chinese Clinical Trial Registry (ChiCTR2200057080). The validation cohort (Peking University First Hospital) was approved by the Institutional Review Board of Peking University First Hospital and registered with the Chinese Clinical Trial Registry (ChiCTR2300074936). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}